Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cleavage and polyadenylation specificity factor subunit 7 (CPSF7) is a protein-coding member of the cleavage factor Im (CFIm) complex, which is essential for pre-mRNA 3'-end cleavage and polyadenylation processing in eukaryotic cells. This processing is necessary for the maturation of messenger RNA (mRNA) and, consequently, for correct gene expression. CPSF7 corresponds to the 59 kDa subunit (CFIm59) of this multiprotein complex and binds to specific RNA sequence signals in the 3'-untranslated region of pre-mRNAs. The CFIm complex regulates alternative polyadenylation events, influencing mRNA stability, localization, and translation—thus playing a significant role in cellular homeostasis and pathology. CPSF7 is upregulated in several cancers, including lung adenocarcinoma and hepatocellular carcinoma, where its overexpression promotes cell proliferation, migration, and invasion, partly via activation of the AKT/mTOR pathway. Targeting CPSF7 or modulating its function is of therapeutic interest but is complicated by its critical role in core RNA processing functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cleavage and polyadenylation specificity factor subunit 7 (CPSF7).